Gamelin Erick 4
4 · Acrivon Therapeutics, Inc. · Filed Nov 18, 2024
Insider Transaction Report
Form 4
Gamelin Erick
Chief Development Officer
Transactions
- Tax Payment
Common Stock
2024-11-14$7.92/sh−402$3,184→ 16,961 total
Footnotes (1)
- [F1]Shares withheld by the Issuer to satisfy the mandatory tax withholding requirement upon vesting of restricted stock units.